Involuntary Groaning Induced by Levodopa Therapy in a Patient With Progressive Supranuclear Palsy
JAMA Neurol 77:1569, Park, J.E., 2020
Withdrawing Amantadine in Dyskinetic Patients with Parkinson Disease
Neurol 82:300-307, Ory-Magne, F.,et al, 2014
Safety and Efficacy of Pallidal or Subthalamic Nucleus Stimulation in Advanced PD
Neurol 56:548-551, Volkmann,J.,et al, 2001
Tolcapone for Parkinson's Disease
The Medical Letter 40:60-61, , 1998
Early Dopaminergic Drug-Induced Hallucinations in Parkinsonian Patients
Neurol 51:811-814, Goetz,C.G.,et al, 1998
Neuroleptic Malignant Synd in Parkinson's after Withdrawal or Alteration of Dopaminergic Therapy
Arch Int Med 151:794-796, Keyser,D.L.&Rodnitzky,R.L., 1991
Cardiac Arrhythmias
In Handbook of Parkinson's Disease, W. C. Koller (ed) , Marcal Dekker, Inc, New York, 1987, p 151., , 1987
Dystonia-Parkinson Syndrome:Differential Effects of Levodopa and Dopamine Agonists
Clin Neuropharmacol 9:298-302, Klawans,H.L.&Paleologos,N., 1986
A Neuroleptic Malignantlike Syndrome Due to Levodopa Therapy Withdrawal
JAMA 254:2792-2795, Friedman,J.H.,et al, 1985
Fatal Hyperpyrexia After Withdrawal of Levodopa
Neurol 34:249-251, Sechi,G.P.,et al, 1984
Meige's Syndrome During Long-term Dopaminergic Therapy in Parkinson's Disease
Arch Neurol 39:451-452, Weiner,W.J.,et al, 1982
Complications of Chronic Levodopa Therapy; Long-term Efficacy of Drug Holiday
Neurol 31:473-476, Koller,W.C.,et al, 1981
Respiratory Dyskinesias:Extrapyramidal Dysfunction & Dyspnea
Ann Int Med 88:327, Weiner,W.J.,et al, 1978
Drug-Induced Movement Disorders
Postgrad Med 180, 1971, Sept., North,R., 1971